Background The World Health Organization has indicated that GPs can safely and
effectively provide mifepristone and misoprostol for medical termination of pregnancy (TOP) …

Abstract Background The World Health Organization (WHO) indicates that General
Practitioners (GPs) can effectively and safely provide mifepristone and misoprostol for …

Abstract Background Australian Government approval in 2012 for the use of mifepristone
and misoprostol for medical termination of pregnancy (MTOP) allows general practitioners …

Background: Medical abortion (using mifepristone followed by misoprostol to end an early
pregnancy) is a more accessible and less invasive option than surgical termination and can …

Objective: Evaluate satisfaction and experience with telemedicine and home use of
mifepristone and misoprostol for abortion to 10 weeks' gestation. Design: Cross-sectional …

Background Australia has demonstrated high efficacy and safety of medical termination of
pregnancy (MToP) using a mifepristone–buccal misoprostol regime. The provision of …

Given the highly political nature of abortion in the United States, the provision of medical
abortion with mifepristone (Mifeprex®) and misoprostol has always occurred under a unique …

Significant changes are occurring in the landscape of abortion provision in the UK. More
women are having medical abortions and self-managing these at home, resulting in an …

Medical abortion is fundamental to women's health care. It provides a safe and effective
alternative to early surgical abortion and can occur in the privacy of a woman's home …

Objectives The gold standard of medication abortion, mifepristone and misoprostol, became
available in Canada in 2017 as a combination pack under the trade name Mifegymiso®. We …